HKG:3186 Holdings Information

HKG:3186 is an equity ETF with a total of 96 individual holdings. The top holdings are Keymed Biosciences stock at 3.25%, Zai Lab at 3.15%, InnoCare Pharma at 2.96%, Sichuan Kelun-Biotech Biopharmaceutical at 2.84%, and Innovent Biologics at 2.75%.

Total Holdings

Top 10 Percentage

27.26%

Asset Class

Equity

ETF Category

Health Care

Assets

24.62M

PE Ratio

20.00

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	HKG: 2162	Keymed Biosciences Inc.	3.25%	11,078
2	HKG: 9688	Zai Lab Limited	3.15%	37,608
3	HKG: 9969	InnoCare Pharma Limited	2.96%	49,427
4	HKG: 6990	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	2.84%	1,512
5	HKG: 1801	Innovent Biologics, Inc.	2.75%	6,993
6	HKG: 6160	BeOne Medicines AG	2.73%	3,155
7	HKG: 3696	InSilico Medicine Cayman TopCo	2.56%	10,344
8	HKG: 3692	Hansoh Pharmaceutical Group Company Limited	2.42%	17,358
9	HKG: 0013	HUTCHMED (China) Limited	2.31%	26,372
10	HKG: 1093	CSPC Pharmaceutical Group Limited	2.29%	63,050
11	HKG: 2096	Simcere Pharmaceutical Group Limited	2.27%	49,937
12	HKG: 1877	Shanghai Junshi Biosciences Co., Ltd.	2.15%	30,455
13	HKG: 1177	Sino Biopharmaceutical Limited	2.13%	95,630
14	HKG: 2196	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	2.09%	29,599
15	HKG: 9995	RemeGen Co., Ltd.	2.05%	6,755
16	HKG: 0867	China Medical System Holdings Limited	2.02%	44,827
17	HKG: 9926	Akeso, Inc.	1.99%	5,400
18	HKG: 6185	CanSino Biologics Inc.	1.83%	17,099
19	HKG: 1952	Everest Medicines Limited	1.78%	15,873
20	HKG: 1530	3SBio Inc.	1.74%	27,214
21	HKG: 1513	Livzon Pharmaceutical Group Inc.	1.72%	20,767
22	JNGHF	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	1.67%	8,878
23	HKG: 2186	Luye Pharma Group Ltd.	1.65%	231,849
24	HKG: 6855	Ascentage Pharma Group International	1.55%	12,859
25	MRNA	Moderna, Inc.	1.54%	314

Showing 25 of 96 holdings

Subscribe to see the full list

Activate Now

As of Sep 18, 2026